Tags |
|
|
Links |
|
|
Digg It - Flash Intros - Don't Do It
At a seminar that I gave last winter, I told a group of marketing pe
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ople that if they were considering Flash Intros that they should ser
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ously reconsider this choice. About half of the group had "uh oh" lo
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
oks on their faces and put their heads down. They had all planned Fl
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
sh Intros and had no idea why these intros are a huge mistake.
Flas
Flas
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
h intros are the bane of users. Users hate waiting for them to load
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
nd about 90% of users skip them anyway. Whenever I see a Flash Intro
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
, I bail out of the site because I don't want to wait for the site t
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
load. This means you are losing site traffic right away and users a
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ren't ever getting an opportunity to view your products or services
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ages. We always tell our clients not to use them because, besides b
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ing usability nightmares, they usually cost quite a bit and don't ad
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
d any value to your site.
Perhaps the only audience who actually wa
Perhaps the only audience who actually wa
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ches these things are marketing people. That's because these pieces
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
are vanity spots touting a company's value. Your users aren't market
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ng people and your Flash Intro is not going to convince them to buy
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
your products or services. Plus, users have seen so many of these i
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
the '90s that they are no longer cool.
Do your bottom line and you
Do your bottom line and you
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
r users a huge favor and don't add a Flash Intro to your site. Your
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
traffic will improve dramatically and so should your sales and leads
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/84190/diggit-Flash-Intros--Dont-Do-It.html">Flash Intros - Don't Do It</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/84190/diggit-Flash-Intros--Dont-Do-It.html]Flash Intros - Don't Do It[/url]
Related Articles:
The Best And Most Effective Way To Market Your Business Online Is Through Articles
Building Trust For Lifetime Success
Bookmark it:
|